| Report Title | Price | Action |
|---|---|---|
| Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021
Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) - Drugs in Development, 2021 Summary Mitogen Activated Protein Kinase Kinase (...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Brachyury Protein (Protein T or T) - Drugs in Development, 2021
Brachyury Protein (Protein T or T) - Drugs in Development, 2021 Summary Brachyury Protein (Protein T or T) - Drugs in Development, 2021 provides in ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Carcinomas (Oncology) - Drugs in Development, 2021
Carcinomas (Oncology) - Drugs in Development, 2021 Summary Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinomas...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Q Fever (Infectious Disease) - Drugs in Development, 2021
Q Fever (Infectious Disease) - Drugs in Development, 2021 Summary Q Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021
Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021 Summary Nicotine Addiction (Central Nervous System) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021
Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Anxiety Disorders (Central Nervous System) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 140
|
$ 2000 | |
| Cysteinyl Leukotriene Receptor 1 (Cysteinyl Leukotriene D4 Receptor or G Protein Coupled Receptor HG55 or HMTMF81 or CYSLTR1) - Drugs in Development, 2021
Cysteinyl Leukotriene Receptor 1 (Cysteinyl Leukotriene D4 Receptor or G Protein Coupled Receptor HG55 or HMTMF81 or CYSLTR1) - Drugs in Development, ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) - Drugs in Development, 2021
Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK/ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2....
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) - Drugs in Development, 2021
Carbonic Anhydrase (Carbonate Dehydratase or Carbonic Acid Anhydrase or Carboxyanhydrase or CA or EC 4.2.1.1) - Drugs in Development, 2021 Summary C...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Macular Degeneration (Ophthalmology) - Drugs in Development, 2021
Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 Summary Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021
Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021 Summary Homozygous Familial Hypercholesterolemia ...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 Summary Non Muscle Invasive Bladder ...
Published: Apr-2021 | No. of Pages: 115
|
$ 2000 | |
| Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021
Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 Summary Arteriosclerosis (Cardiovascular) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) - Drugs in Development, 2021
Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) - Drugs in Development, 2021 Summary Double Homeobox Protein 4 (Double Homeobox Prote...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Myotonin Protein Kinase (DM Kinase or DM1 Protein Kinase or Thymopoietin Homolog or Myotonin Protein Kinase A or Myotonic Dystrophy Associated Protein Kinase or DMPK or EC 2.7.11.1) - Drugs in Development, 2021
Myotonin Protein Kinase (DM Kinase or DM1 Protein Kinase or Thymopoietin Homolog or Myotonin Protein Kinase A or Myotonic Dystrophy Associated Protein...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021
Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 Summary Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 provides in depth an...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Drug Toxicity (Toxicology) - Drugs in Development, 2021
Drug Toxicity (Toxicology) - Drugs in Development, 2021 Summary Drug Toxicity (Toxicology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021
Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Polyarticular Juvenile Idiopathi...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021
Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 Summary Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Arthritis (Musculoskeletal) - Drugs in Development, 2021
Arthritis (Musculoskeletal) - Drugs in Development, 2021 Summary Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 105
|
$ 2000 |